Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fung

Showing results (471-480 of 494) with videos related to

Pageof 50
Sort By:
Alimentary Pharmacology & Therapeutics|November 1, 2001
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled studyB C Wong, W H Wang, W M Wong, et al.
Circulation|July 2, 2008
Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressureDaniel T O'Connor, Gu Zhu, Fangwen Rao, et al.
Journal of the American College of Cardiology|November 20, 2008
Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashionYuqing Chen, Fangwen Rao, Juan L Rodriguez-Flores, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infectionB C Wong, W M Wong, Y K Yee, et al.
The Journal of Emergency Medicine|February 23, 2025
Implementation of an Emergency Department Opioid Use Disorder Initiative: Clinical Processes and Institution Specific Education Improve CareAaron Krumheuer, Alexander T Janke, Alex Nickel, et al.
Cellular and Molecular Neurobiology|November 10, 2010
Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal diseaseYuqing Chen, Fangwen Rao, Gen Wen, et al.
Genome Research|December 22, 2021
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancersAneta Mikulasova, Daniel Kent, Marco Trevisan-Herraz, et al.
American Journal of Perinatology|May 28, 2025
Maternal Area of Residence and Outcomes for Mother-Infant Dyads with Perinatal Opioid ExposureAdrienne Pahl, Zhuopei Hu, Leslie W Young, et al.
JAMA Network Open|January 15, 2021
Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled TrialElizabeth J Sutton, Lior Z Braunstein, Mahmoud B El-Tamer, et al.
The Journal of Pediatrics|October 19, 2025
Antenatal Exposure to Medication for Opioid Use Disorder and Infant Outcomes in the Eat, Sleep, Console for Neonatal Opioid Withdrawal Randomized Controlled TrialSandra G S Beauman, Zhuopei Hu, Ward Rice, et al.
Pageof 50

Showing results (471-480 of 494) with videos related to

Sort By:
Pageof 50
Alimentary Pharmacology & Therapeutics|November 1, 2001
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled studyB C Wong, W H Wang, W M Wong, et al.
Circulation|July 2, 2008
Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressureDaniel T O'Connor, Gu Zhu, Fangwen Rao, et al.
Journal of the American College of Cardiology|November 20, 2008
Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashionYuqing Chen, Fangwen Rao, Juan L Rodriguez-Flores, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infectionB C Wong, W M Wong, Y K Yee, et al.
The Journal of Emergency Medicine|February 23, 2025
Implementation of an Emergency Department Opioid Use Disorder Initiative: Clinical Processes and Institution Specific Education Improve CareAaron Krumheuer, Alexander T Janke, Alex Nickel, et al.
Cellular and Molecular Neurobiology|November 10, 2010
Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal diseaseYuqing Chen, Fangwen Rao, Gen Wen, et al.
Genome Research|December 22, 2021
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancersAneta Mikulasova, Daniel Kent, Marco Trevisan-Herraz, et al.
American Journal of Perinatology|May 28, 2025
Maternal Area of Residence and Outcomes for Mother-Infant Dyads with Perinatal Opioid ExposureAdrienne Pahl, Zhuopei Hu, Leslie W Young, et al.
JAMA Network Open|January 15, 2021
Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled TrialElizabeth J Sutton, Lior Z Braunstein, Mahmoud B El-Tamer, et al.
The Journal of Pediatrics|October 19, 2025
Antenatal Exposure to Medication for Opioid Use Disorder and Infant Outcomes in the Eat, Sleep, Console for Neonatal Opioid Withdrawal Randomized Controlled TrialSandra G S Beauman, Zhuopei Hu, Ward Rice, et al.
Pageof 50